IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors

Hallmarks of Cancer: The Next Generation

2011 • 58,651 citations

Inflammation and cancer

2002 • 14,174 citations

Myeloid-derived suppressor cells as regulators of the immune system

2009 • 6,165 citations

Interleukin-12 and the regulation of innate resistance and adaptive immunity

2003 • 3,689 citations

Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN

2009 • 2,751 citations

Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes

2006 • 2,500 citations

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

1996 • 1,908 citations

Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer

2009 • 1,676 citations

T Lymphocyte-Directed Gene Therapy for ADA ⁻ SCID: Initial Trial Results After 4 Years

1995 • 1,464 citations

Macrophages, innate immunity and cancer: balance, tolerance, and diversity

2010 • 1,410 citations

Gene Transfer into Humans — Immunotherapy of Patients with Advanced Melanoma, Using Tumor-Infiltrating Lymphocytes Modified by Retroviral Gene Transduction

1990 • 1,307 citations

Antitumor and antimetastatic activity of interleukin 12 against murine tumors.

1993 • 1,206 citations

Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell–suppressive activity

2008 • 1,185 citations

Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor Antigens

1994 • 1,185 citations

Distinct Effects of T-bet in T _H 1 Lineage Commitment and IFN-γ Production in CD4 and CD8 T Cells

2002 • 1,169 citations

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells

2005 • 1,000 citations

Tumor Regression and Autoimmunity after Reversal of a Functionally Tolerant State of Self-reactive CD8+ T Cells

2003 • 919 citations

Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production.

1994 • 796 citations

Effects of Single-Dose Interleukin-12 Exposure on Interleukin-12–Associated Toxicity and Interferon-γ Production

1997 • 788 citations

CD8+ T Cell Immunity Against a Tumor/Self-Antigen Is Augmented by CD4+ T Helper Cells and Hindered by Naturally Occurring T Regulatory Cells

2005 • 741 citations

Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function

2006 • 726 citations

Interleukin-12 in anti-tumor immunity and immunotherapy

2002 • 663 citations

Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFNγ receptors

1994 • 619 citations

Myeloid-derived suppressor cell heterogeneity and subset definition

2010 • 617 citations

Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes

2010 • 598 citations

Immune resistance orchestrated by the tumor microenvironment

2006 • 422 citations

Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockade.

2000 • 421 citations

Interleukin-10 and the immune response against cancer: a counterpoint

2005 • 393 citations

Induced sensitization of tumor stroma leads to eradication of established cancer by T cells

2007 • 353 citations

Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice

2011 • 334 citations

Cutting Edge: IL-12 Inversely Regulates T-bet and Eomesodermin Expression during Pathogen-Induced CD8+ T Cell Differentiation

2006 • 323 citations

Apoptotic Death of CD8+ T Lymphocytes After Immunization: Induction of a Suppressive Population of Mac-1+/Gr-1+ Cells

1998 • 321 citations

Tolerance and Cancer: Mechanisms of Tumor Evasion and Strategies for Breaking Tolerance

2004 • 319 citations

The Anti-Tumor Activity of IL-12: Mechanisms of Innate Immunity That Are Model and Dose Dependent

2000 • 304 citations

MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy

2011 • 269 citations

Bystander elimination of antigen loss variants in established tumors

2004 • 259 citations

Improving Adoptive T Cell Therapy by Targeting and Controlling IL-12 Expression to the Tumor Environment

2011 • 257 citations

Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

2010 • 243 citations

Restoration of T-cell homeostasis after T-cell depletion

1997 • 218 citations

Immunotherapy of cancer by IL-12-based cytokine combinations

2007 • 215 citations

Engineering lymphocyte subsets: tools, trials and tribulations

2009 • 202 citations

IL-12 initiates tumor rejection via lymphoid tissue–inducer cells bearing the natural cytotoxicity receptor NKp46

2010 • 201 citations

Intratumoral Injection of Dendritic Cells Engineered to Secrete Interleukin-12 by Recombinant Adenovirus in Patients With Metastatic Gastrointestinal Carcinomas

2004 • 176 citations

IFN-γ– and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancers

2008 • 148 citations

Phase I Trial of Concurrent Twice-Weekly Recombinant Human Interleukin-12 Plus Low-Dose IL-2 in Patients With Melanoma or Renal Cell Carcinoma

2003 • 137 citations

Reversing Tumor Immune Suppression with Intratumoral IL-12: Activation of Tumor-Associated T Effector/Memory Cells, Induction of T Suppressor Apoptosis, and Infiltration of CD8+ T Effectors

2006 • 131 citations

Adoptive T cell therapy of cancer

2010 • 114 citations

IL-12 in conjunction with dendritic cells enhances antiviral CD8+ CTL responses in vitro.

1996 • 111 citations

Genetic Engineering of Murine CD8+ and CD4+ T Cells for Preclinical Adoptive Immunotherapy Studies

2011 • 87 citations

Immunotherapy prospects for acute myeloid leukaemia

2010 • 82 citations

Equilibrium between Host and Cancer Caused by Effector T Cells Killing Tumor Stroma

2008 • 69 citations

IL-12/IL-2 combination cytokine therapy for solid tumours: translation from bench to bedside

2002 • 52 citations

T-Cell Engineering for Cancer Immunotherapy

2009 • 42 citations

The genetic modification of T cells for cancer therapy: an overview of laboratory and clinical trials.

1994 • 42 citations

Retrovirus-mediated gene transfer into CD4+ and CD8+ human T cell subsets derived from tumor-infiltrating lymphocytes and peripheral blood mononuclear cells

1991 • 33 citations

Intracutaneous Genetic Immunization with Autologous Melanoma-Associated Antigen Pmel17/gp100 Induces T Cell-Mediated Tumor Protection In Vivo

2000 • 18 citations